Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FNVUN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,019
Award facts
- Contract value 100% obligated
- $12,019.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,019.28 delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated significant capability in fulfilling federal medical procurement requirements through its extensive portfolio of competitive awards with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems. This particular delivery order for Ocrevus, a specialty pharmaceutical used in neurological treatment, exemplifies the company's role as a critical vendor for specialized medical supply needs within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FNVUN?
SPE2DB25FNVUN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FNVUN worth?
The government has obligated $12,019 on SPE2DB25FNVUN.
Is contract SPE2DB25FNVUN an order under another contract?
Yes. SPE2DB25FNVUN is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVUN competed?
The extent of competition for SPE2DB25FNVUN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award